Biotech entity

Axonics

Company

Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Boston Scientific, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Axonics, all published on March 23, 2026.

Last mentioned: Mar 23, 2026

Entity pulse

Recent coverage · Axonics

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Axonics

Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Boston Scientific, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Axonics, all published on March 23, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Axonics. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Lead Plaintiff Deadline

    Expected deadline for shareholders to petition the court to serve as lead plaintiff in the case.

  2. Follow-up Disclosure

    Secondary announcements highlight the filing and the process for shareholders to join the litigation.

  3. Class Action Announcement

    Pomerantz LLP first alerts investors to the class action filing against Boston Scientific.

Stories mentioning Axonics 1

Pharma Neutral

Boston Scientific Faces Class Action Scrutiny Over Securities Disclosures

Pomerantz LLP has initiated a class action lawsuit against Boston Scientific (BSX), alleging potential violations of federal securities laws. The litigation centers on the company's disclosures during a period of significant expansion and product integration, marking a critical legal challenge for the medical device giant.

2 sources

Axonics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.